clonidine has been researched along with Abdominal Migraine in 91 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacies of an 2-agonist clonidine and an 2-antagonist mianserin were compared in two treatment groups, common migraine and tension headache sufferers." | 5.05 | Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists. ( Agnoli, A; Denaro, A; Manna, V; Martucci, N; Ruggieri, S, 1985) |
| " For hemicrania we used cinnarizine, cyproheptadine, clonidine, histamine, pizotifene and reserpine; for cluster headache, cinnarizine, cyproheptadine, clonidine, histamine and reserpine; for tension headache, cyproheptadine; for psychogenic headache, allylpropylmalonylurea." | 5.04 | [Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1975) |
| "Baclofen, tizanidine and botulinum toxin A, agents used to treat disorders of muscle tone, have been studied as potential preventative treatments for migraine, tension-type headache and other related disorders." | 4.82 | Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role? ( Freitag, FG, 2003) |
| " In order to elucidate the relationship between noradrenergic and opioidergic functions, the plasma beta-endorphin (beta-EP) response to clonidine and the cortisol response to dexamethasone were evaluated together in 25 patients suffering from migraine without aura, and with chronic tension headache (MTH)." | 3.67 | Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine. ( Facchinetti, F; Genazzani, AR; Martignoni, E; Nappi, G; Rossi, F; Sances, G, 1989) |
| " The dosage of metoprolol was 50 mg b." | 2.66 | Metoprolol v. clonidine in the prophylactic treatment of migraine. ( Hedman, C; Louis, P; Schoenen, J, 1985) |
| " The daily dosage of propranolol and clonidine was 160 mg and 100 microgram, respectively." | 2.65 | Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial. ( Kåss, B; Nestvold, K, 1980) |
| "Various drugs have been used in migraine to bring down the frequency of attacks." | 2.65 | Clonidine in prophylaxis of migraine. ( Ahuja, GK; Das, SM; Narainaswamy, AS, 1979) |
| "The prophylactic effect of clonidine in a dosage of 0." | 2.64 | Clonidine in the prophylaxis of migraine. ( Boisen, E; Deth, S; Hübbe, P; Jansen, J; Klee, A; Leunbach, G, 1978) |
| "Clonidine and placebo were given for 7 weeks each, but only the last 5 weeks in each period were used for the statistical evaluation." | 2.64 | Clonidine (Catapresan)-double-blind study after long-term treatment with the drug in migraine. ( Sjaastad, O; Stensrud, P, 1976) |
| "Clonidine was the most frequently prescribed (49." | 1.42 | Prescribing patterns of anti-migraine medicines in South Africa using a claims database. ( Truter, I, 2015) |
| "Chronic migraine is an important public health problem." | 1.36 | Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. ( D'Amico, D, 2010) |
| "Usage patterns of specific migraine prophylactic drugs were evaluated for each patient by accessing data from a large prescription database and were characterized as continued, switch or stop use during the patient observation period." | 1.32 | Migraine prophylactic medication usage patterns in The Netherlands. ( Buurma, H; Egberts, AC; Leufkens, HG; Rahimtoola, H; Tijssen, CC, 2003) |
| " A marked suppressive effect on cortisol secretion was observed in the migrainous patients after acute and chronic administration of clonidine." | 1.27 | Basal plasma HGH and cortisol levels and the effect of clonidine administration in female migrainous patients. ( Bechar, M; Gil-Ad, I; Hering, R; Laron, Z; Tyano, S; Weizman, A; Weizman, R, 1984) |
| "Patients having one or more attacks of migraine a week may need prophylactic treatment." | 1.26 | [The use of drugs in migraine]. ( Wilkinson, M, 1976) |
| " The therapeutic cycles were standardized, for each drug, in the way of administration, dosage and total duration of the treatment." | 1.26 | [Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases]. ( Agostoni, A; Brandi, G; Cottino, A; Gai, V; Gastaldi, L; Lisino, F; Nattero, G, 1976) |
| "Three of the migraine subjects had raised basal plasma noradrenaline levels but all had been taking clonidine up to 12-24 hr before the test and the increased plasma noradrenaline levels were probably due to the effect of withdrawal of the drug." | 1.26 | The metabolic and hormonal response to glucagon. Part 2. In patients with migraine. ( Capildeo, R; Goodwin, PM; Harrop, JS; Marks, V; Rose, FC, 1976) |
| "The demonstration that long-term administration of relatively low doses of clonidine decreased the responsiveness of blood vessels to vasodilator and vasoconstrictor drugs in animals led to its investigation in the prevention of migraine in man." | 1.25 | Low-dose clonidine: a review of its therapeutic efficacy in migraine prophylaxis. ( Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 78 (85.71) | 18.7374 |
| 1990's | 6 (6.59) | 18.2507 |
| 2000's | 5 (5.49) | 29.6817 |
| 2010's | 2 (2.20) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Truter, I | 1 |
| D'Amico, D | 1 |
| Freitag, FG | 1 |
| Rahimtoola, H | 1 |
| Buurma, H | 1 |
| Tijssen, CC | 1 |
| Leufkens, HG | 1 |
| Egberts, AC | 1 |
| Ignatov, IuD | 1 |
| Skoromets, AA | 1 |
| Amelin, AV | 1 |
| Rapoport, AM | 1 |
| Bigal, ME | 1 |
| Richter, F | 1 |
| Mikulik, O | 1 |
| Ebersberger, A | 1 |
| Schaible, HG | 1 |
| Agnoli, A | 3 |
| Denaro, A | 2 |
| Ceci, E | 1 |
| Falaschi, P | 1 |
| Johnson, JM | 1 |
| Sills, M | 1 |
| Congdon, P | 1 |
| Forsythe, I | 1 |
| Sicuteri, F | 1 |
| Centonze, V | 1 |
| Brucoli, C | 1 |
| Attolini, E | 1 |
| Macinagrossa, G | 1 |
| Sabbà, C | 1 |
| Campanozzi, F | 1 |
| Albano, O | 1 |
| Wood, J | 1 |
| Lance, J | 1 |
| Weizman, A | 1 |
| Gil-Ad, I | 1 |
| Weizman, R | 1 |
| Hering, R | 1 |
| Bechar, M | 1 |
| Tyano, S | 1 |
| Laron, Z | 1 |
| Lian, QS | 1 |
| Ambielli, M | 1 |
| Kåss, B | 1 |
| Nestvold, K | 1 |
| Hakkarainen, H | 2 |
| Kokkanen, E | 1 |
| Kallanranta, T | 2 |
| Mylecharane, EJ | 2 |
| Duckworth, JW | 2 |
| Lord, GD | 2 |
| Lance, JW | 4 |
| Diamond, S | 2 |
| Medina, JL | 1 |
| Hermann, C | 1 |
| Kim, M | 1 |
| Blanchard, EB | 1 |
| Wiedemann, M | 1 |
| de Lima, VM | 1 |
| Hanke, W | 1 |
| Meyer, C | 1 |
| Shtok, VN | 1 |
| Pigarev, VA | 1 |
| Fanchamps, A | 2 |
| Pozniak-Patewicz, E | 1 |
| Glover, V | 1 |
| Sandler, M | 1 |
| Grant, E | 1 |
| Rose, FC | 2 |
| Orton, D | 1 |
| Wilkinson, M | 4 |
| Stevens, D | 1 |
| Wahlberg, P | 1 |
| Spira, PJ | 1 |
| Fozard, JR | 1 |
| Sillanpää, M | 1 |
| Mondrup, K | 1 |
| Moller, CE | 1 |
| Boisen, E | 2 |
| Deth, S | 1 |
| Hübbe, P | 1 |
| Jansen, J | 1 |
| Klee, A | 2 |
| Leunbach, G | 1 |
| Adam, EI | 1 |
| Gore, SM | 1 |
| Price, WH | 1 |
| Wood, RA | 1 |
| Das, SM | 1 |
| Ahuja, GK | 1 |
| Narainaswamy, AS | 1 |
| Barolin, GS | 1 |
| Congdon, PJ | 1 |
| Forsythe, WI | 1 |
| Hackaday, J | 1 |
| Isler, H | 1 |
| Critchley, EM | 1 |
| Stensrud, P | 2 |
| Sjaastad, O | 2 |
| Nattero, G | 2 |
| Agostoni, A | 2 |
| Brandi, G | 2 |
| Cottino, A | 2 |
| Gai, V | 2 |
| Gastaldi, L | 2 |
| Lisino, F | 2 |
| Damato, H | 1 |
| Hokkanen, E | 1 |
| Tuovinen, T | 1 |
| Ryan, RE | 6 |
| Lynggaard, F | 1 |
| Ostergaard, F | 1 |
| White, G | 1 |
| Munro, J | 1 |
| Coote, NP | 1 |
| Brogden, RN | 1 |
| Pinder, RM | 1 |
| Sawyer, PR | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Corbat, F | 1 |
| Goodwin, PM | 1 |
| Capildeo, R | 1 |
| Harrop, JS | 1 |
| Marks, V | 1 |
| Callaghan, N | 1 |
| Green, C | 1 |
| Horowitz, I | 1 |
| Martignoni, E | 2 |
| Facchinetti, F | 2 |
| Rossi, F | 1 |
| Sances, G | 2 |
| Genazzani, AR | 2 |
| Nappi, G | 2 |
| Bredfeldt, RC | 1 |
| Sutherland, JE | 1 |
| Kruse, JE | 1 |
| Massiou, H | 1 |
| Bousser, MG | 1 |
| Prusiński, A | 1 |
| Petraglia, F | 1 |
| Manzoni, GC | 1 |
| Sandrini, G | 1 |
| Martucci, N | 2 |
| Manna, V | 2 |
| Porto, C | 1 |
| Louis, P | 1 |
| Schoenen, J | 1 |
| Hedman, C | 1 |
| Ruggieri, S | 1 |
| Frewin, DB | 1 |
| Rozniecki, J | 1 |
| Durward, WF | 1 |
| Shafar, J | 2 |
| Tallett, ER | 2 |
| Knowlson, PA | 2 |
| Nurick, S | 1 |
| Pollard, PA | 1 |
| Wall, MC | 2 |
| Saxena, PR | 1 |
| de Vlaam-Schluter, GM | 1 |
| Anthony, M | 2 |
| Somerville, B | 1 |
| Sharpe, CJ | 1 |
| Heathfield, KW | 1 |
| Raiman, JD | 1 |
| Patten, JP | 1 |
| Levens, LK | 1 |
| Hanington, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population[NCT03055767] | Phase 2 | 17 participants (Actual) | Interventional | 2017-03-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Open-Label Period" (NCT03055767)
Timeframe: Duration of migraine in hours during the open-label period (2 additional rounds of onabotulinumtoxinA) as compared to the cross-over period.
| Intervention | Duration of migraine in hours during the open-labe (hours) |
|---|---|
| Cross-Over Period | Median |
| "Open-Label Period | Median |
Open-label Period" (NCT03055767)
Timeframe: The frequency of migraines during the open-label period (2 additional rounds of onabotulinumtoxinA) as compared to the cross-over period.
| Intervention | The frequency of migraines during the open-label p (days) |
|---|---|
| "Open-Label Period | Median |
Open-Label Period" (NCT03055767)
Timeframe: "Intensity of migraines during the the open-label period (2 additional rounds of onabotulinumtoxinA) as compared to the cross-over period.~Intensity based on 0-10 Pain Numeric Rating Score (NRS). The higher the score, the more intense the pain."
| Intervention | "Intensity of migraines during the the open-label (units on a scale) |
|---|---|
| Cross-Over Period | Median |
| "Open-Label Period | Median |
Open-Label Period" (NCT03055767)
Timeframe: "The PedMIDAS the open-label period (2 additional rounds of onabotulinumtoxinA) as compared to the cross-over period.~The PedMIDAS consists of 6 questions: 3 addressing school attendance and functioning, and 3 evaluating participation in events outside of
| Intervention | "The PedMIDAS the open-label period (2 additional (score on a scale) |
|---|---|
| Cross-Over Period | Median |
| "Open-Label Period | Median |
Number of concomitant headache medications taken (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | number taken (Median) |
|---|---|
| "Baseline Period | 3 |
| Botox Period | 1 |
| Placebo Period | 2 |
Subject reported having difficulty sleeping (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | Participants (Count of Participants) |
|---|---|
| "Baseline Period | 12 |
| Botox Period | 5 |
| Placebo Period | 11 |
The duration of benefit in weeks (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | weeks (Median) |
|---|---|
| Botox Period | 4 |
| Placebo Period | 0 |
Subject visited an Emergency Department (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | Participants (Count of Participants) |
|---|---|
| "Baseline Period | 8 |
| Botox Period | 2 |
| Placebo Period | 3 |
The frequency of migraines in days. (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | days (Median) |
|---|---|
| "Baseline Period | 28 |
| Botox Period | 20 |
| Placebo Period | 28 |
"Improvement of functionality as determined by their Pediatric Migraine Disability Score (PedMIDAS). The PedMIDAS consists of 6 questions: 3 addressing school attendance and functioning, and 3 evaluating participation in events outside of school. The questionnaire is based on the patient's recall of the previous 3 months.~The questionnaire produces a raw score (0-10, 11-30, 31-50, >50) corresponding to a disability grade with increasing severity (little to non, mild, moderate, and severe) which was coded (1, 2, 3, and 4)." (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | score on a scale (Median) |
|---|---|
| Botox Period | 1 |
| Placebo Period | 0 |
Subject is home schooled full-time. (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post, respective intervention
| Intervention | Participants (Count of Participants) |
|---|---|
| "Baseline Period | 2 |
| Botox Period | 2 |
| Placebo Period | 2 |
Admission to hospital (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | Participants (Count of Participants) |
|---|---|
| "Baseline Period | 8 |
| Botox Period | 0 |
| Placebo Period | 2 |
Median intensity of migraines based on 0-10 Pain Numeric Rating Score (NRS). The higher the score, the more intense the pain. (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | units on a scale (Median) |
|---|---|
| "Baseline Period | 8 |
| Botox Period | 5 |
| Placebo Period | 7 |
Duration of migraines in hours. (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | hours (Median) |
|---|---|
| "Baseline Period | 24 |
| Botox Period | 10 |
| Placebo Period | 24 |
"Pediatric Migraine Disability Score consists of 6 questions: 3 addressing school attendance and functioning, and 3 evaluating participation in events outside of school. The questionnaire is based on the patient's recall of the previous 3 months.~The questionnaire produces a raw score (0-10, 11-30, 31-50, >50) corresponding to a disability grade with increasing severity (little to non, mild, moderate, and severe) which was coded (1, 2, 3, and 4)." (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | score on a scale (Median) |
|---|---|
| "Baseline Period | 4 |
| Botox Period | 3 |
| Placebo Period | 4 |
Subject is enrolled in a school plan such as IEP, 504 plan, or similar modified school schedule. (NCT03055767)
Timeframe: Baseline (4 weeks) and 12 weeks post each, respective intervention
| Intervention | Participants (Count of Participants) |
|---|---|
| "Baseline Period | 11 |
| Botox Period | 10 |
| Placebo Period | 10 |
15 reviews available for clonidine and Abdominal Migraine
| Article | Year |
|---|---|
Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
Topics: Baclofen; Botulinum Toxins, Type A; Clonidine; GABA Agonists; Humans; Migraine Disorders; Muscle Rel | 2003 |
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, No | 2003 |
Preventive migraine therapy: what is new.
Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Second-Generation; Anti | 2004 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
The role of clonidine in the treatment of migraine: a review of the literature and personal experience.
Topics: Age Factors; Clinical Trials as Topic; Clonidine; Double-Blind Method; Humans; Migraine Disorders; P | 1980 |
Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis.
Topics: Behavioral Medicine; Biofeedback, Psychology; Child; Clonidine; Dopamine Agents; Humans; Migraine Di | 1995 |
[Treatment of migraine].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Analgesics; Antidepressive Agents, Tricyclic; Cinnar | 1979 |
The animal pharmacology of drugs used in the treatment of migraine.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cypr | 1975 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinep | 1975 |
The therapeutic uses of clonidine.
Topics: Blood Pressure; Climacteric; Clonidine; Female; Glaucoma; Hemodynamics; Humans; Hypertension; Kidney | 1979 |
Monotherapy or polytherapy in migraine.
Topics: Barbiturates; Clonidine; Dihydroergotamine; Drug Combinations; Humans; Migraine Disorders; Pizotylin | 1987 |
Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Bradykinin; Carotid Arteries | 1974 |
Current concepts in the pathogenesis and interval treatment of migraine.
Topics: Adrenergic beta-Antagonists; Bradykinin; Clonidine; Cycloheptanes; Cyproheptadine; Ergotamine; Hista | 1972 |
[Clonidine (Catapresan) in prevention of migraine].
Topics: Clonidine; Depression; Fatigue; Humans; Migraine Disorders; Placebos; Time Factors | 1973 |
Migraine.
Topics: Blood Vessels; Cacao; Cheese; Clonidine; Diet Therapy; Eye Diseases; Food; Headache; Hematologic Dis | 1971 |
24 trials available for clonidine and Abdominal Migraine
| Article | Year |
|---|---|
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Clonidine and childhood migraine: a pilot and double-blind study.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Eruptions; F | 1982 |
[Therapy of migraine crises: experience with clonidine].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clonidine; Drug Evaluation; Female; Humans; Male; Middl | 1983 |
Clonidine and migraine.
Topics: Clinical Trials as Topic; Clonidine; Humans; Migraine Disorders | 1984 |
Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Ergotamine; Female; Humans; Male; M | 1980 |
The role of clonidine in the treatment of migraine: a review of the literature and personal experience.
Topics: Age Factors; Clinical Trials as Topic; Clonidine; Double-Blind Method; Humans; Migraine Disorders; P | 1980 |
Clonidine prophylaxis of childhood migraine and other vascular headache. A double blind study of 57 children;.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Female; Headache; Humans; | 1977 |
Prophylactic treatment of migraine with clonidine. A controlled clinical trial.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Evaluation; Female | 1977 |
Clonidine in the prophylaxis of migraine.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Evaluation; Female; Humans; Ma | 1978 |
Double blind trial of clonidine in the treatment of migraine in a general practice.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Clonidine; Double-Blind Method; Family Pra | 1978 |
Clonidine in prophylaxis of migraine.
Topics: Adult; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1979 |
Clonidine (Catapresan)-double-blind study after long-term treatment with the drug in migraine.
Topics: Adult; Clinical Trials as Topic; Clonidine; Drug Evaluation; Female; Humans; Male; Middle Aged; Migr | 1976 |
[Therapeutic possibilities in idiopathic headaches. Analysis of 1000 cases (author's transl)].
Topics: Aspirin; Caffeine; Cinnarizine; Clinical Trials as Topic; Clonidine; Cyproheptadine; Drug Therapy, C | 1975 |
Clonidine--its use in migraine therapy.
Topics: Adult; Clinical Trials as Topic; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1975 |
[Clonidine in prevention of migraine. Report of a double-blind study of 38 patients referred for neurological assessment].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clonidine; Drug Evaluation; Female; Humans; Male; Middl | 1975 |
Double blind study of clonidine and placebo for the prophylactic treatment of migraine.
Topics: Clinical Trials as Topic; Clonidine; Female; Humans; Male; Migraine Disorders; Placebos | 1975 |
[Clonidin in the treatment of migraine (author's transl)].
Topics: Blood Vessels; Clonidine; Drug Antagonism; Humans; Migraine Disorders; Vasoconstrictor Agents; Vasod | 1976 |
Efficacy of transdermal clonidine for headache prophylaxis and reduction of narcotic use in migraine patients. A randomized crossover trial.
Topics: Administration, Cutaneous; Adult; Clinical Trials as Topic; Clonidine; Data Collection; Double-Blind | 1989 |
Migraine and the noradrenergic control of vasomotricity: a study with alpha-2 stimulant and alpha-2 blocker drugs.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dibenzazepines; Double-Blind Method; Female; Headache; H | 1985 |
Metoprolol v. clonidine in the prophylactic treatment of migraine.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Double-Blind Method | 1985 |
Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dibenzazepines; Double-Blind Method; Female; Headache; H | 1985 |
Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Clonidine; Female; Follo | 1972 |
Clonidine for migraine.
Topics: Clinical Trials as Topic; Clonidine; Humans; Migraine Disorders | 1972 |
Preliminary report on the use of clonidine (Boehringer Ingelheim) in the treatment of migraine.
Topics: Adult; Clinical Trials as Topic; Clonidine; Evaluation Studies as Topic; Female; Humans; Male; Middl | 1970 |
54 other studies available for clonidine and Abdominal Migraine
| Article | Year |
|---|---|
Prescribing patterns of anti-migraine medicines in South Africa using a claims database.
Topics: Adult; Clonidine; Databases, Factual; Drugs, Generic; Female; Humans; Insurance, Health, Reimburseme | 2015 |
Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.
Topics: Amines; Analgesics; Chronic Disease; Clonidine; Cyclohexanecarboxylic Acids; Diagnosis, Differential | 2010 |
Migraine prophylactic medication usage patterns in The Netherlands.
Topics: Adrenergic beta-Antagonists; Adult; Analgesics; Calcium Channel Blockers; Clonidine; Drug Combinatio | 2003 |
Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Blood Press | 2005 |
On the etiopathogenesis of migraine: a possible link between the amines and endorphin hypotheses.
Topics: Adult; Clonidine; Dopamine; Endorphins; Enkephalin, Methionine; Enkephalins; Female; Histamine; Huma | 1982 |
Inhibition of peptidase degrading endogenous opioids: a new trend in the management of migraine and correlated "pain diseases".
Topics: Brain; Captopril; Clonidine; Cluster Headache; Endorphins; Humans; Migraine Disorders; Nociceptors; | 1983 |
Basal plasma HGH and cortisol levels and the effect of clonidine administration in female migrainous patients.
Topics: Adolescent; Adult; Clonidine; Female; Follow-Up Studies; Growth Hormone; Humans; Hydrocortisone; Mig | 1984 |
[Pharmacology of clonidine and its clinical application].
Topics: Animals; Blood Pressure; Brain; Clonidine; Humans; Hypertension; Migraine Disorders; Opioid-Related | 1983 |
Drug stop: migraine headache. Current therapy.
Topics: Adolescent; Adult; Child; Clonidine; Diet; Ergot Alkaloids; Female; Humans; Male; Middle Aged; Migra | 1982 |
Effects of low doses of clonidine in the monkey cranial circulation.
Topics: Animals; Blood Pressure; Cerebrovascular Circulation; Clonidine; Dose-Response Relationship, Drug; H | 1980 |
Newer drug therapies for headache.
Topics: Antidepressive Agents; Aspirin; Bromocriptine; Clonidine; Cluster Headache; Dipyridamole; Headache; | 1980 |
Effects of antimigraine drugs on retinal spreading depression.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Adrenochrome; Analgesics, Non-Narcotic; Animals; Aspirin | 1996 |
[Treatment of migraine (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Caffeine; Child; Clonidine; Drug Therapy, | 1975 |
[Mechanism of action of drugs currently used in the prevention of migraine].
Topics: Adrenergic beta-Antagonists; Catecholamines; Cerebrovascular Circulation; Chemical Phenomena; Chemis | 1976 |
Clonidine in acute migraine.
Topics: Acute Disease; Adult; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1976 |
Transitory decrease in platelet monoamine-oxidase activity during migraine attacks.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Blood Proteins; Child; Child, Preschool; Clonidine; Dia | 1977 |
Two types of migraine.
Topics: Adrenergic beta-Antagonists; Clonidine; Humans; Migraine Disorders; Temperature | 1979 |
Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
Topics: Acetylcholine; Animals; Bradykinin; Cerebrovascular Circulation; Cimetidine; Clonidine; Dose-Respons | 1978 |
[Drug therapy for headache: (author's transl)].
Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamin | 1977 |
Migraine in childhood. A review.
Topics: Acute Disease; Age Factors; Anticonvulsants; Child; Child, Preschool; Clonidine; Ergotamines; Female | 1979 |
Migraine. Prophylactic drugs.
Topics: Anticonvulsants; Clonidine; Cyproheptadine; Dihydroergotamine; Humans; Methysergide; Migraine Disord | 1977 |
[Therapy of migraine and vasomotor cephalea].
Topics: Adrenal Cortex Hormones; Analgesics; Antidepressive Agents; Barbiturates; Clonidine; Ergotamines; Hu | 1978 |
The diagnosis and management of migraine.
Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Aspirin; Child; Clonidine; Ergotamine; Ergotamines; F | 1978 |
Prophylaxis of migraine.
Topics: Adult; Aged; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1977 |
Clonidine in migraine prophylaxis.
Topics: Adult; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders; Practolol | 1977 |
Drugs for migraine.
Topics: Caffeine; Clonidine; Drug Synergism; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Migrain | 1976 |
[The use of drugs in migraine].
Topics: Acetaminophen; Antiemetics; Aspirin; Clonidine; Dihydroergotamine; Ergotamine; Humans; Hypnotics and | 1976 |
[Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases].
Topics: Cinnarizine; Clonidine; Cyproheptadine; Headache; Histamine; Humans; Methysergide; Migraine Disorder | 1976 |
The effects of clonidine in the prophylactic treatment of migraine.
Topics: Adult; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1975 |
Letter: Clinical evaluation of clonidine in the treatment of migraine.
Topics: Adolescent; Adult; Aged; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders | 1975 |
Letter: Clonidine in the treatment of migraine.
Topics: Adult; Clonidine; Female; Humans; Male; Migraine Disorders | 1975 |
Letter: Treatment of migraine with piracetam and clonidine.
Topics: Clonidine; Drug Therapy, Combination; Humans; Male; Migraine Disorders; Piracetam; Pyrrolidinones | 1975 |
Low-dose clonidine: a review of its therapeutic efficacy in migraine prophylaxis.
Topics: Clonidine; Humans; Migraine Disorders; Placebos; Time Factors | 1975 |
The metabolic and hormonal response to glucagon. Part 2. In patients with migraine.
Topics: Adult; Blood Glucose; Clonidine; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Growth H | 1976 |
Management of migraine.
Topics: Adrenal Cortex Hormones; Aspirin; Clonidine; Humans; Indoles; Migraine Disorders; Propranolol; Sulfo | 1992 |
Sumatriptan and other drugs used in migraine treatment.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricycl | 1992 |
Clonidine in migraine prophylaxis--now obsolete.
Topics: Clonidine; Humans; Migraine Disorders | 1990 |
Clonidine dosage.
Topics: Clonidine; Humans; Migraine Disorders | 1990 |
Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine.
Topics: Adult; beta-Endorphin; Clonidine; Dexamethasone; Female; Headache; Humans; Hydrocortisone; Male; Mid | 1989 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnariz | 1986 |
Endorphin patterns within the headache spectrum disorders.
Topics: Adrenocorticotropic Hormone; Adult; beta-Endorphin; Chronic Disease; Clonidine; Cluster Headache; De | 1985 |
Clonidine. Quo vadis?
Topics: Adrenal Gland Neoplasms; Anxiety Disorders; Climacteric; Clonidine; Female; Humans; Hypertension; Mi | 1985 |
[Less known indications for the use of clonidine].
Topics: Alcohol Amnestic Disorder; Brain Diseases; Clonidine; Glaucoma; Humans; Migraine Disorders; Opioid-R | 1985 |
The management of migraine.
Topics: Clonidine; Diet; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Pizotyli | 1985 |
Clonidine in migraine.
Topics: Antihypertensive Agents; Clonidine; Humans; Imidazoles; Migraine Disorders | 1972 |
Clonidine in migraine.
Topics: Antihypertensive Agents; Clonidine; Humans; Imidazoles; Migraine Disorders; Time Factors | 1972 |
Clonidine against migraine.
Topics: Adolescent; Adult; Aged; Child; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorders; Re | 1973 |
A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Animals; Anticonvulsants; Antihypertensive Age | 1972 |
Letter: Propranolol in the treatment of migraine.
Topics: Adult; Cardiomyopathy, Hypertrophic; Clonidine; Female; Humans; Male; Middle Aged; Migraine Disorder | 1974 |
The long-term management of migraine with clonidine.
Topics: Adolescent; Adult; Child; Clonidine; Female; Humans; Long-Term Care; Male; Middle Aged; Migraine Dis | 1972 |
Atypical migraine.
Topics: Aneurysm; Anxiety; Blood Pressure; Clonidine; Diagnosis, Differential; Ergotamine; Headache; Humans; | 1973 |
Dixarit--a treatment for migraine.
Topics: Clonidine; Humans; Migraine Disorders | 1973 |
[Drug information. Catapresan 25. A new migraine remedy on the market].
Topics: Clonidine; Humans; Migraine Disorders | 1973 |
Letter: Clonidine in treatment of dysmenorrhea.
Topics: Clonidine; Dysmenorrhea; Female; Humans; Migraine Disorders; Uterus | 1974 |